| A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT05085028) | Imperial College London | 2022-06-23 |
| Breathe Easier II: A Dyad-based Multiple Behavior Intervention (NCT05956782) | University of South Carolina | 2022-06-15 |
| Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System (NCT06722885) | Universitair Ziekenhuis Brussel | 2022-01-01 |
| Effect of Exercise Training in Lung Cancer (NCT05158530) | Riphah International University | 2021-12-20 |
| Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) (NCT04611867) | Inna Chen, MD | 2021-08-17 |
| Pulmonary Function After Arterial Sleeve Lobectomy (NCT04981938) | Centre Hospitalier Régional Universitaire Montpellier | 2021-07-22 |
| This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols. (NCT05061940) | Repertoire Immune Medicines | 2021-05-05 |
| Trial of NanoPac Intratumoral Injection in Lung Cancer (NCT04314895) | NanOlogy, LLC | 2021-04-14 |
| [18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients (NCT04678440) | University of California, Davis | 2021-03-31 |
| Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients (NCT04222335) | University Hospital, Toulouse | 2021-03-26 |
| Cios Mobile 3D Spin for Robotic Bronchoscopy (NCT04740047) | Mayo Clinic | 2021-02-01 |
| A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer (NCT06405815) | Jinling Hospital, China | 2021-01-01 |
| Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity (NCT04631731) | Western Sydney Local Health District | 2020-12-15 |
| Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients (NCT04566432) | Geneplus-Beijing Co. Ltd. | 2020-07-01 |
| Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment (NCT04440800) | Royal Marsden NHS Foundation Trust | 2020-07-01 |
| A Multicenter Cancer Biospecimen Collection Study (NCT04510129) | Cofactor Genomics, Inc. | 2020-02-05 |
| Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC (NCT04028778) | Sun Yat-sen University | 2019-04-10 |
| Move For Surgery - A Novel Preconditioning Program (NCT03689634) | St. Joseph's Healthcare Hamilton | 2018-10-15 |
| Palliative Thoracic ImmunoRT (NCT03705806) | University Health Network, Toronto | 2018-10-03 |
| Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA (NCT03499678) | HKGepitherapeutics | 2018-07-01 |
| Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer (NCT03377023) | H. Lee Moffitt Cancer Center and Research Institute | 2018-02-02 |
| Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer (NCT03088930) | University of Colorado, Denver | 2017-12-13 |
| Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery (NCT03902834) | St. Joseph's Healthcare Hamilton | 2017-11-30 |
| Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating (NCT03322072) | CancerCare Manitoba | 2017-11-23 |
| The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung (NCT04634630) | Beatrice Aramini | 2017-10-17 |
| Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. (NCT03245736) | Seagen Inc. | 2017-08-23 |
| Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China (NCT03059641) | Geneplus-Beijing Co. Ltd. | 2017-02-22 |
| Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC (NCT03008109) | Zaiwen Fan | 2017-02-01 |
| Effect of Qigong on the Symptom Clusters of Dyspnea, Fatigue, and Anxiety. (NCT02977845) | Nam Dinh University of Nursing | 2017-01-01 |
| Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC (NCT02991651) | Io Therapeutics | 2016-12-07 |
| A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients (NCT04237805) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2016-11-14 |
| Plasmodium Immunotherapy for Lung Cancer (NCT02786589) | State Key Laboratory of Respiratory Disease | 2016-06-27 |